TrialBritish journal of cancer1999

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

Y Tokuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.